GSE115328
CC-122 versus Lenalidomide
Gene expression profiles of OSU-CLL cells were tested after exposure to CC-122 (0.1 and 1 micromolar), Lenalidomide (1 micromolar), or DMSO, at 5 and 24 hours Overall design: Examination of 4 drug conditions at 2 timepoints